Question 1

What is idiopathic pulmonary fibrosis (IPF)?

Accepted Answer

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung condition of unknown cause, where scar tissue (fibrosis) gradually thickens and stiffens the lung tissue surrounding the air sacs (alveoli), reducing breathing capacity and gas exchange Source: NHLBI (NIH)

Question 2

What causes idiopathic pulmonary fibrosis?

Accepted Answer

The exact cause is unknown (“idiopathic”), but risk factors include cigarette smoking, genetic predisposition, viral infections, gastroesophageal reflux disease (GERD), and environmental exposures such as wood or metal dust. These factors may trigger abnormal wound-healing leading to fibrosis Source: MedlinePlus Genetics

Question 3

What are the symptoms of idiopathic pulmonary fibrosis?

Accepted Answer

Typical symptoms include progressive shortness of breath (especially with exertion), a persistent dry cough, fatigue, unintended weight loss, and clubbing (widening) of the fingertips. Fine crackles (“velcro” sounds) may also be present on lung examination Source: Wikipedia (clinical features)

Question 4

How is idiopathic pulmonary fibrosis diagnosed?

Accepted Answer

Doctors may use a combination of medical history, lung function tests, high-resolution CT scans, and sometimes a lung biopsy to confirm an IPF diagnosis.

Question 5

How is idiopathic pulmonary fibrosis treated?

Accepted Answer

Though there is no cure, treatment may slow progression and improve quality of life: FDA-approved antifibrotic medications such as pirfenidone and nintedanib, oxygen therapy, pulmonary rehabilitation, and in suitable patients, lung transplantation Source: Mayo Clinic

Question 6

Can idiopathic pulmonary fibrosis be cured?

Accepted Answer

No—IPF is progressive and currently incurable. However, approved treatments can help slow lung function decline and improve symptom control; lung transplantation may significantly extend survival in selected patients Source: StatPearls (NCBI)

Question 7

How common is idiopathic pulmonary fibrosis?

Accepted Answer

IPF is a rare disease affecting approximately 100,000 people in the U.S., with about 30,000–40,000 new cases diagnosed annually. Estimated U.S. prevalence ranges between 14–42 per 100,000 people Source: Healthline summarizing NIH data

Question 8

How fast does idiopathic pulmonary fibrosis progress?

Accepted Answer

Progression varies by individual. Some people may experience slow decline over years, while others may see a more rapid loss of lung function. Regular monitoring is key.

Question 9

Is idiopathic pulmonary fibrosis the same as COPD?

Accepted Answer

No. While both are chronic lung diseases, IPF involves lung scarring, whereas COPD is caused by airway inflammation and obstruction. They have different causes, symptoms, and treatments.

Question 10

Who is at risk for idiopathic pulmonary fibrosis?

Accepted Answer

Older adults, especially those over 60, are at higher risk. Smoking history, exposure to environmental pollutants, and having family members with lung disease may also increase risk.

Idiopathic Pulmonary Fibrosis Medications